echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Synthetic Routes of Imidazo[1,2-b]pyridazine-2-carboxylic acid (9CI)

    The Synthetic Routes of Imidazo[1,2-b]pyridazine-2-carboxylic acid (9CI)

    • Last Update: 2023-05-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Synthetic Routes of Imidazo[1,2-b]pyridazine-2-carboxylic acid (9CI) in the Chemical Industry


    Imidazo[1,2-b]pyridazine-2-carboxylic acid (9CI) is an important organic compound with a wide range of applications in the chemical industry.
    It is used as a building block for the synthesis of various industrial chemicals, pharmaceuticals, and agrochemicals.
    The synthesis of 9CI involves several steps, and the choice of synthetic route depends on the availability of starting materials, the desired yield, and the cost of the process.
    In this article, we will discuss the different synthetic routes of 9CI in the chemical industry.


    One of the most common methods of synthesizing 9CI is through the reaction of 2-amino-1,3-benzoxazepine with chloroform in the presence of sodium hydroxide.
    The reaction results in the formation of N-chloramine, which is then reduced to N-aminomethylidene by hydrogenation in the presence of a catalyst.
    The final step involves the decarboxylation of the N-aminomethylidene derivative to yield 9CI.


    Another synthetic route involves the reaction of 2-aminopyridine with bromoacetamide in the presence of triethylamine.
    The reaction results in the formation of 2-bromo-1,3-oxazepine, which is then hydrolyzed to yield 2-amino-1,3-oxazepine.
    The latter is then reacted with chloroform and sodium hydroxide to yield 9CI.


    A third synthetic route involves the reaction of 2-aminopyridine with iodomethane in the presence of triethylamine.
    The reaction results in the formation of 2-iodo-1,3-oxazepine, which is then hydrolyzed to yield 2-amino-1,3-oxazepine.
    The latter is then reacted with chloroform and sodium hydroxide to yield 9CI.


    The choice of synthetic route will depend on the availability of starting materials, the desired yield, and the cost of the process.
    The three routes outlined above are some of the most common methods of synthesizing 9CI, but there are also other methods that have been reported in the literature.


    In conclusion, the synthetic routes of imidazo[1,2-b]pyridazine-2-carboxylic acid (9CI) in the chemical industry are varied and depend on the availability of starting materials, the desired yield, and the cost of the process.
    The three routes outlined above are some of the most common methods of synthesizing 9CI, but there are also other methods that have been reported in the literature.
    Regardless of the route chosen, 9CI is an important building block for the synthesis of various industrial chemicals, pharmaceuticals, and agrochemicals, and its synthesis continues to be an active area of research in the chemical industry.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.